Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Power3 Medical Products, a proteomics company specializing in the development and commercialization of diagnostic blood tests for early detection of breast cancer and neurodegenerative diseases, has appointed Helen Park as its new interim CEO.
Subscribe to our email newsletter
Steven Rash has resigned as CEO and chairman of Power3. Mr Rash’s employment ceased on September 3, 2008, as did his service as a director of the company.
Ms Park currently serves as a consultant to biotechnology companies in the Houston, Texas area on issues concerning business management reorganization. Ms Park has an MS in biochemistry at Baylor College of Medicine with more than 40 years of experience in science and biotechnology business management.
Ira Goldknopf, president and chief scientific officer of Power3, said: “Helen brings a wealth of experience in science and biotechnology business management. We believe that, with her leadership, the company will continue to complete the development of our blood serum diagnostic tests for breast cancer and neurodegenerative diseases, BC SerPro and NuroPro.”